Using a pragmatically adapted, low-cost contingency management intervention to promote heroin abstinence in individuals undergoing treatment for heroin use disorder in UK drug services (PRAISE): a cluster randomised trial
Julian Mutz,
Andrew Pickles,
Sarah Byford,
John Dunn,
Kimberley Goldsmith,
Franziska Mosler,
Tim Weaver,
James Shearer,
Emily Finch,
John Strang,
Clare Davey,
Stephen Pilling,
Anthony Glasper,
Nicola Metrebian,
Jennifer Hellier,
Luke Mitcheson,
Prun Bijral,
Nadine Bogdan,
Owen Bowden-Jones,
Edward Day,
Sam Forshall,
Shabana Akhtar,
Jalpa Bajaria,
Carmel Bennett,
Elizabeth Bishop,
Vikki Charles,
Roopal Desai,
Claire Goodfellow,
Farjana Haque,
Nicholas Little,
Hortencia McKechnie,
Jo Morris,
Ruth Pauli,
Dilkushi Poovendran,
Elizabeth Phillips
Affiliations
Julian Mutz
Addictions, King`s College London, Institute of Psychiatry, Psychology and Neuroscience, London, UK
Andrew Pickles
Department of Biostatistics and Health Informatics, Institute of Psychiatry, Psychology and Neuroscience, King`s College London, London, UK
Sarah Byford
4 Health Service and Population Research Department, Institute of Psychiatry, Psychology and Neuroscience, King`s College London, London, UK
John Dunn
2 Pharmacy, Ninewells Hospital, Dundee, UK
Kimberley Goldsmith
Department of Biostatistics and Health Informatics, Institute of Psychiatry, Psychology & Neuroscience, King`s College London, London, UK
Franziska Mosler
Addictions, King`s College London, Institute of Psychiatry, Psychology and Neuroscience, London, UK
Tim Weaver
3 Department of Mental Health & Social Work, Middlesex University, London, UK
James Shearer
4 Health Service and Population Research Department, Institute of Psychiatry, Psychology and Neuroscience, King`s College London, London, UK
Emily Finch
Psychiatry, South London and Maudsley National Health Service Foundation Trust (SLaM) & Institute of Psychiatry, Psychology & Neuroscience (IoPPN), London, UK
John Strang
Addictions, Kings College London, London, UK
Clare Davey
Drug and Alcohol Services, Avon and Wiltshire Mental Health Partnership NHS Trust, Bath, UK
Stephen Pilling
Centre for Outcomes Research and Effectiveness (CORE), Research Department of Clinical, Educational and Health Psychology, University College London, London, UK
Anthony Glasper
Substancce Misuse Service, Sussex Partnership NHS Foundation Trust, Worthing, UK
Nicola Metrebian
Addictions, King`s College London, Institute of Psychiatry, Psychology and Neuroscience, London, UK
Jennifer Hellier
Biostatistics and Health Informatics, King`s College London, Institute of Psychiatry, Psychology and Neuroscience, London, UK
Luke Mitcheson
Addictions Department, King`s College London Institute of Psychiatry Psychology and Neuroscience, London, UK
Prun Bijral
Management Offices, Change Grow Live, Manchester, UK
Nadine Bogdan
Sankey House, Essex Partnership University NHS Foundation Trust, Pitsea,Essex, UK
Owen Bowden-Jones
Addictions and Substance Misuse, Central and North West London NHS Foundation Trust, London, UK
Edward Day
Addiction Services, Birmingham and Solihull Mental Health NHS Foundation Trust, Birmingham, UK
Sam Forshall
Drug and Alcohol Services, Avon and Wiltshire Mental Health Partnership NHS Trust, Bath, UK
Shabana Akhtar
Addiction Services, Birmingham and Solihull Mental Health NHS Foundation Trust, Birmingham, UK
Jalpa Bajaria
Sankey House, Essex Partnership University NHS Foundation Trust, Pitsea,Essex, UK
Carmel Bennett
Addiction Services, Birmingham and Solihull Mental Health NHS Foundation Trust, Birmingham, UK
Elizabeth Bishop
Centre for Outcomes, Research and Effectiveness, University College London, London, UK
Vikki Charles
Addictions, King`s College London, Institute of Psychiatry, Psychology and Neuroscience, London, UK
Roopal Desai
Addictions, King`s College London, Institute of Psychiatry, Psychology and Neuroscience, London, UK
Claire Goodfellow
Centre for Outcomes, Research and Effectiveness, University College London, London, UK
Farjana Haque
Addictions, King`s College London, Institute of Psychiatry, Psychology and Neuroscience, London, UK
Nicholas Little
Centre for Outcomes, Research and Effectiveness, University College London, London, UK
Hortencia McKechnie
Addictions, King`s College London, Institute of Psychiatry, Psychology and Neuroscience, London, UK
Jo Morris
Drug and Alcohol Services, Avon and Wiltshire Mental Health Partnership NHS Trust, Bath, UK
Ruth Pauli
Addiction Services, Birmingham and Solihull Mental Health NHS Foundation Trust, Birmingham, UK
Dilkushi Poovendran
Centre for Mental Health, Imperial College London, London, UK
Elizabeth Phillips
Sankey House, Essex Partnership University NHS Foundation Trust, Pitsea,Essex, UK
Introduction Most individuals treated for heroin use disorder receive opioid agonist treatment (OAT)(methadone or buprenorphine). However, OAT is associated with high attrition and persistent, occasional heroin use. There is some evidence for the effectiveness of contingency management (CM), a behavioural intervention involving modest financial incentives, in encouraging drug abstinence when applied adjunctively with OAT. UK drug services have a minimal track record of applying CM and limited resources to implement it. We assessed a CM intervention pragmatically adapted for ease of implementation in UK drug services to promote heroin abstinence among individuals receiving OAT.Design Cluster randomised controlled trial.Setting and participants 552 adults with heroin use disorder (target 660) enrolled from 34 clusters (drug treatment clinics) in England between November 2012 and October 2015.Interventions Clusters were randomly allocated 1:1:1 to OAT plus 12× weekly appointments with: (1) CM targeted at opiate abstinence at appointments (CM Abstinence); (2) CM targeted at on-time attendance at appointments (CM Attendance); or (3) no CM (treatment as usual; TAU). Modifications included monitoring behaviour weekly and fixed incentives schedule.Measurements Primary outcome: heroin abstinence measured by heroin-free urines (weeks 9–12). Secondary outcomes: heroin abstinence 12 weeks after discontinuation of CM (weeks 21–24); attendance; self-reported drug use, physical and mental health.Results CM Attendance was superior to TAU in encouraging heroin abstinence. Odds of a heroin-negative urine in weeks 9–12 was statistically significantly greater in CM Attendance compared with TAU (OR=2.1; 95% CI 1.1 to 3.9; p=0.030). CM Abstinence was not superior to TAU (OR=1.6; 95% CI 0.9 to 3.0; p=0.146) or CM Attendance (OR=1.3; 95% CI 0.7 to 2.4; p=0.438) (not statistically significant differences). Reductions in heroin use were not sustained at 21–24 weeks. No differences between groups in self-reported heroin use.Conclusions A pragmatically adapted CM intervention for routine use in UK drug services was moderately effective in encouraging heroin abstinence compared with no CM only when targeted at attendance. CM targeted at abstinence was not effective.Trial registration number ISRCTN 01591254.